Mounjaro 7mg: the third step in your treatment journey

Step 1: understanding what "7mg Mounjaro" actually refers to

There is a widely held belief that Mounjaro comes in a 7mg strength. It does not. The UK-licensed doses of tirzepatide are 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg, as set out in the Summary of Product Characteristics on the Electronic Medicines Compendium. The confusion almost certainly arises because people searching after a dose increase remember "seven-something" and round down. So if you have been prescribed what you think of as "7mg Mounjaro", you are almost certainly on 7.5mg, and the clinical facts on this page apply to that step.

The titration ladder matters here. Treatment starts at 2.5mg, a tolerability dose whose job is to let your digestive system adapt rather than to produce significant weight change. After four weeks, most people move to 5mg. Then, if 5mg is well tolerated, 7.5mg. Each increase happens at the prescriber's discretion, informed by how the previous pen went. At Mounjaro 5mg, appetite suppression often becomes noticeable; by 7.5mg that effect tends to be more consistent and sustained across the week.

One short sentence worth repeating clearly: there is no 7mg tirzepatide pen sold in the UK.

Step 2: what changes clinically at the 7.5mg dose

Reaching 7.5mg means you have completed at least eight weeks on Mounjaro. By this point your body has had time to adjust to tirzepatide's dual-receptor mechanism, and the 7.5mg pen tends to produce a more pronounced and stable reduction in hunger between doses. Clinical trial data from SURMOUNT-1, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% over 72 weeks at the highest dose of 15mg, but the journey to that figure runs through 7.5mg. Weight change at intermediate doses is real, though variable between individuals.

Side effects at 7.5mg follow the same GI-led pattern as earlier increases: nausea, indigestion, and sometimes looser stools are the most commonly reported, and they are most pronounced in the first few days after the new dose, then typically ease. If you found the 5mg increase straightforward, there is reasonable clinical expectation that 7.5mg will be similar. The NHS tirzepatide page explains what to watch for at each stage and when to contact your prescriber.

It is also worth knowing that women on oral contraceptives are advised to use an additional non-oral method for four weeks after each dose increase, because tirzepatide slows gastric emptying in a way that may reduce pill absorption. That advice applies at 7.5mg just as it did at 5mg.

Step 3: deciding whether you are ready to move to 7.5mg

The decision to increase from 5mg to 7.5mg is a clinical one. Our guidance on moving up a Mounjaro dose covers the signals your prescriber looks for: whether nausea has settled, whether hunger is returning toward the end of each week, and whether there are any reasons to hold the current dose longer. Some people stay at 5mg for an extra four weeks because it is working well enough and they prefer a cautious approach. Others move on schedule. Neither is wrong; the prescriber judges.

At the cost level, the 7.5mg pen is priced differently from starter doses, and the overall picture of what is included in a private prescription service matters, consultation, clinical review, the prescription itself, and delivery should all be part of a transparent quote. A prescriber at a GPhC-registered pharmacy reviews your progress before each repeat, not once at the start.

If 7.5mg is well tolerated and weight progress stalls, 10mg and 12.5mg are the subsequent steps, up to a licensed maximum of 15mg. The full picture of how Mounjaro works across the dose schedule puts 7.5mg in context as a mid-range step, not the endpoint. People sometimes assume the "right" dose is the highest available; in practice, many find a lower maintenance dose that suits them, and that is a conversation to have with their prescriber. Eating well on treatment matters too, breakfast choices on Mounjaro are a simple, practical way to support the appetite reduction the medicine provides.

Step 4: getting clinical review for this dose through a regulated route

Mounjaro at any dose, including 7.5mg, is a prescription-only medicine. That means a prescriber must assess your suitability before each supply, not only at first prescription, but at each repeat. Our clinical team carries out that review personally, every time. For people transferring from another service at 7.5mg, evidence of current treatment is required before our prescribers will continue or increase a dose, a precaution that protects you as much as it protects clinical standards.

If you are considering whether Mounjaro is the right route for your situation, speaking to a prescriber is the practical first step. There are no waiting lists and no referral needed through a private regulated pharmacy; our free consultation is where that conversation starts, and a clinician reviews your answers the same day. That is the straightforward process, whatever dose you end up on.